[Second resection in patients with Ta-T1 bladder tumors]

Area of Science:

• Urology
• Oncology
• Surgical Pathology

Context:

• Superficial bladder tumors require careful management to ensure complete eradication.
• Repeat transurethral resection (TUR) is sometimes performed to address potential residual or recurrent disease.
• The efficacy and necessity of a second TUR for Ta-T1 bladder tumors remain subjects of investigation.

Purpose:

• To determine the incidence of residual or recurrent bladder tumors after a second transurethral resection (2nd TUR).
• To evaluate the effectiveness of a second TUR in achieving complete tumor removal for superficial bladder cancer.
• To explore potential factors influencing tumor detection in a second TUR.

Summary:

• A repeat transurethral resection (TUR) was performed on 40 patients with superficial bladder tumors within three months of initial resection.
• Tumor was detected in 37.8% (14 of 37) of patients staged as Ta-T1 after the second TUR.
• No significant correlation was found between the presence of residual tumor and variables such as time between resections, tumor stage, grade, or size.

Impact:

• Findings indicate that complete tumor removal is not consistently achieved with initial transurethral resection (TUR) for superficial bladder tumors.
• The study highlights that early cystoscopy may miss residual disease.
• Routine second TUR for superficial bladder cancer is not recommended based on these findings, suggesting a need for refined surveillance strategies.